Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
During Xenopus embryogenesis, XId3, a member of the Id helix-loop-helix protein family, is expressed in a large variety of differentiating tissues including epidermis, cement gland, brain, neural tube, neural crest cell derivatives, somites, and tailbud. Transcription of XId3 is mediated by several cis-regulatory elements including an enhancer of 440 bp located 870 bp upstream from the transcription initiation site. The enhancer activity in embryos was studied using transgenic methodology. A galactosidase reporter gene, driven by a regulatory element composed of the enhancer and a minimal promoter derived from the XId3 gene, was expressed in transgenic embryos with a profile that faithfully reproduced that of the endogenous XId3 gene. The pattern resulted from a synergistic effect between the enhancer and the promoter, and in vitro transactivation assays showed that transcription can be stimulated by Notch signaling. The presence of potential Su(H) binding sites, in both the enhancer and the promoter, suggests that these represent candidates for in vivo cis-regulatory elements. The data presented here suggest that Notch control of differentiation may involve activation of transcription of Id, a negative regulator of bHLH transcription factors.
Fig. 1 Activity of CAT reporter
genes driven by enhancer
and promoter elements derived
from the XId3 gene in Xenopus
embryos. A Constructs used to
determine location and activity
of the GTG enhancer. (a)
Map of the upstream part of
the Xenopus XId3 gene showing
the location of the GTG enhancer
and of restriction sites
relevant for the construction
of the reporter genes. (b) CAT
reporter genes with progressively
5ø-deleted upstream sequences
from the XId3 promoter.
(c) The GTG Enhancer,
the tetrameric oligo GTG1 and
GTG2 constructs and a minimal
c-myc promoter construct
used as a control. B CAT activity
assay performed with each
construct described in b. As
control for basic CAT activity,
the minimal c-myc reporter
was used. C Comparison of the
GTG enhancer activity with
different 5ø-deleted Id promoter
constructs. D Activity assay
for the GTG1 and GTG2 constructs
in parallel with the
GTG enhancer.
Fig. 2 Expression driven by
the XId3 enhancer/promoter
tandem in transgenic embryos
and expression of the endogenous
gene determined by in
situ hybridization. A A
plasmid containing the galactosidase
encoding sequence
driven by the XId3 enhancer/
promoter tandem was linearized
with NotI and used to
create transgenic embryos as
described. In this experiment,
11 out of 22 neurulae stained
positively for galactosidase,
nine of them are shown. The
two embryos that are not
shown stained very strongly
with abnormal development
similar to embryo number 3.
Brightness and contrast of embryo
number 1 has been raised
to visualize the asymmetric expression
in right and left side
somites. B Three selected embryos
showing a regular and
consistent transgene expression
pattern. C Tailbud stage of a
transgenic embryo expressing
the XId3 driven galactosidase
gene. The transgene is strongly
expressed in the growing apex
of the tailbud, where cells have
a maximal proliferation rate,
and progressively silenced in
the differentiating somites, and
finally reduced to a pattern
corresponding to the ordered
myotome nuclei. D Higher
magnification of an embryo
showing transgene expression
in the skin (Sk), brain (B),
spinal cord (Sp), eye vesicle
(Ey), ear vesicle (Ea), cement
gland (Ce), neural crest derivatives
(Nc), notochord (No),
myotomes (My) and tailbud
(Tb). E Whole-mount in situ
hybridization of tailbud stage
embryos with a XId3 RNA
probe. The major positive signals,
represented in brown
color, are indicated. Abbreviations
are as in 2B.
Fig. 3 Expression driven by the XId3 enhancer/promoter tandem
visualized in sections of transgenic embryos. In this embryo, the
left side stained more intensively than the right one. The sections
are oblique with respect to the dorsal axis. As a consequence the
notochord and the neural tube appear elongated. A Oblique section
of the head area of a tailbud stage embryo showing a scattered
staining pattern. B Oblique section of the central body part of the
embryo shown in A. Dorsal fin (Df), spinal cord (Sp), myotomes
(My) and notochord (No) are indicated.
Fig. 4 Immunocytochemical detection of Id protein in developing
Xenopus embryos. A A stage 22 embryo. B Head of a stage 35
embryo. Staining is observed in brain (B), eye (Ey), neural crest
derivatives (Nc), cement gland (Ce) and skin (Sk). C Tail of a stage
35 embryo. D Magnified view of somites from C.
Fig. 5 GTG enhancer and promoter of the XId3 gene. Nucleotide
sequence of the GTG enhancer (A) and of the proximal promoter
(B) of the XId3 gene. The potential Su(H) binding sites, the DraIII,
SspI and EcoRI restriction sites are boxed, the TATA box is underlined.
The areas from which the synthetic oligonucleotides GTG1
and GTG2 were derived are indicated with arrowed lines.
Fig. 6 Transactivation by Notch, in an oocyte assay system, of a
CAT reporter gene driven by the GTG enhancer, GTG1 and GTG2
constructs. A Cartoon illustrating the transactivation assay. Oocytes
are microinjected with a mRNA encoding the cytoplasmic
portion of Notch or, as a control, the mutated form of Notch
described in the text. Eight hours later, the CAT reporter gene is
injected into the germinal vesicle. 20â24 hours later the oocytes
are lysed in at least triplicate batches of 10â20 oocytes each, an
extract is prepared, and CAT activity determined. B Transactivation
by Xenopus Notch mRNA of CAT reporter genes driven by
GTG-Enhancer-, GTG1- and GTG2-constructs. Approximately
150 oocytes were injected with each Notch mRNA and 8 hours
later with the indicated reporter genes (50 oocytes/reporter gene) as
indicated under Methods. Extracts were prepared for CAT activity
determination another 24 hours later. C Comparison of the abilities
of mouse and Xenopus Notch to transactivate the GTG1-CAT
constructs. Injections were performed and oocytes processed as described
under B.